Kids with Diabetes Worse Off Than Adults
As the obesity rate among young people has climbed, so has the rate of type 2 diabetes. Adolescents who get the disease may face more health problems than those who get it as an adult.
FDA Drug Safety Communication: Rosiglitazone-containing Medicines
The U.S. Food and Drug Administration (FDA) is informing the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines.
The Warning is on the Label
The FDA is notifying the public that information on the cardiovascular risks (including heart attack) of the diabetes drug rosiglitazone has been added to the physician labeling and patient Medication Guide.